Study Evaluating The Safety And Efficacy Of PF-03654746 In Adult Subjects With Tourette's Syndrome
Status:
Withdrawn
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of an investigational
compound designated PF-03654746 compared to placebo in the treatment of adults with
Tourette's Syndrome. The study will also explore the pharmacokinetics of PF-03654746 in
adults with Tourette's Syndrome.